atezolizumab,obinutuzumab
roche
['atezo', 'obinu', 'lymsm', 'leusm']
molto a ph2 trial in richter transformation #lymsm #leusm using ven-atezolizumab-obinu showed orr 67% and cr 28%, pfs 16 mo. another option in a difficult disease #asco23
An associate member @MoffittNews with interest in #lymsm. Tweets are not endorsements, and not medical advice.